Tissue Regeneration

Houston, Texas, September 1, 2026 FibroBiologics, Inc. has announced the issuance of a new U.S. patent covering a potential...

Houston, Texas, August 20, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing regenerative therapies based on fibroblast cells and...

FRANKLIN, Tenn., August 18, 2026 Lynch Regenerative Medicine (LRM) announced the completion of enrollment in an investigator-initiated Phase II...

HOUSTON, August 18, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing therapies based on fibroblast cells and fibroblast-derived materials,...

NEEDHAM, Massachusetts, August 11, 2026 Mighty Therapeutics, a commercial-stage biotechnology company focused on therapies targeting mitochondrial dysfunction, and a...

HOUSTON, Texas, August 11, 2026 FibroBiologics, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued...

PRINCETON, N.J., June 1, 2026 Made Scientific has been selected as the manufacturing partner for Columbia University’s NOVAKnee program,...